Timsina Roshan, Shrestha Upasana, Singh Anjana, Timalsina Bivek
Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal.
Center for Health & Disease Studies-Nepal (CHDS), Shankhamul, Kathmandu, Nepal.
Future Sci OA. 2020 Oct 20;7(1):FSO361. doi: 10.2144/fsoa-2020-0092.
Resistance to methicillin and Macrolide-Lincosamide and Streptogramins B and their association with genes in are unknown in Nepal.
MATERIALS & METHODS: Nonduplicate nasal swabs from 160 school children were collected from April to September 2018 and processed using standard microbiological procedures.
Out of 160 samples, 64 (40%) were in which 17 (26.6%) were methicillin-resistance (MRSA). D-test identified 15 (23.4%) as inducible clindamycin-resistant, which were more prevalent in MRSA (76.4%) than methicillin-sensitive (MSSA; 4.2%). 18.7% of isolates harbored the gene followed by (15.6%) and (3.1%), and were more in MRSA than MSSA.
To prevent treatment failure by inducible resistance, D-test must be performed on erythromycin-resistant and/or clindamycin-sensitive isolates.
在尼泊尔,耐甲氧西林、大环内酯-林可酰胺-链阳菌素B及其与基因的关联尚不清楚。
2018年4月至9月收集了160名学童的非重复鼻拭子,并采用标准微生物学程序进行处理。
在160份样本中,64份(40%)为金黄色葡萄球菌,其中17份(26.6%)为耐甲氧西林金黄色葡萄球菌(MRSA)。D试验确定15份(23.4%)为诱导型克林霉素耐药,在MRSA中比甲氧西林敏感金黄色葡萄球菌(MSSA;4.2%)更普遍。18.7%的分离株携带erm基因,其次是mef(15.6%)和vga(3.1%),且在MRSA中比MSSA中更多见。
为防止诱导耐药导致治疗失败,必须对红霉素耐药和/或克林霉素敏感的分离株进行D试验。